Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS PHARMACIE DE LA CLARENCE : revenue, balance sheet and financial ratios

SELAS PHARMACIE DE LA CLARENCE is a French company founded 25 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LAPUGNOY (62122), this company of category PME shows in 2025 a net income positive of 236 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE DE LA CLARENCE (SIREN 433213949)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 235 693 € 249 201 € 327 479 € 217 634 € 96 517 € 160 193 € 268 753 € 311 170 € 201 865 € 227 795 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SELAS PHARMACIE DE LA CLARENCE generates positive net income of 236 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 228 k€ -> 236 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

235 693 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

50.769%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

59.82%

Solvency indicators evolution
SELAS PHARMACIE DE LA CLARENCE

Sector positioning

Debt ratio
50.77 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average -5 pts over 3 years

In 2025, the debt ratio of SELAS PHARMACIE DE LA CLA... (50.77) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
59.82% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good +14 pts over 3 years

In 2025, the financial autonomy of SELAS PHARMACIE DE LA CLA... (59.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Positioning of SELAS PHARMACIE DE LA CLARENCE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELAS PHARMACIE DE LA CLARENCE is estimated at 3 744 011 € (range 2 540 703€ - 5 874 869€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2540k€ 3744k€ 5874k€
3 744 011 € Range: 2 540 703€ - 5 874 869€
NAF 5 année 2025

Valuation method used

Net Income Multiple
235 693 € × 15.9x = 3 744 011 €
Range: 2 540 704€ - 5 874 869€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE DE LA CLARENCE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE DE LA CLARENCE

What is the revenue of SELAS PHARMACIE DE LA CLARENCE ?

The revenue of SELAS PHARMACIE DE LA CLARENCE is not publicly disclosed (confidential accounts filed with INPI).

Is SELAS PHARMACIE DE LA CLARENCE profitable?

Yes, SELAS PHARMACIE DE LA CLARENCE generated a net profit of 236 k€ in 2025.

Where is the headquarters of SELAS PHARMACIE DE LA CLARENCE ?

The headquarters of SELAS PHARMACIE DE LA CLARENCE is located in LAPUGNOY (62122), in the department Pas-de-Calais.

Where to find the tax return of SELAS PHARMACIE DE LA CLARENCE ?

The tax return of SELAS PHARMACIE DE LA CLARENCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE DE LA CLARENCE operate?

SELAS PHARMACIE DE LA CLARENCE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.